A detailed history of Rhenman & Partners Asset Management Ab transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 195,000 shares of IONS stock, worth $7.12 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
195,000
Previous 130,000 50.0%
Holding current value
$7.12 Million
Previous $6.2 Million 26.09%
% of portfolio
0.65%
Previous 0.61%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$40.06 - $51.86 $2.6 Million - $3.37 Million
65,000 Added 50.0%
195,000 $7.81 Million
Q2 2024

Aug 13, 2024

BUY
$36.45 - $47.7 $4.74 Million - $6.2 Million
130,000 New
130,000 $6.2 Million
Q2 2022

Aug 12, 2022

SELL
$31.71 - $43.0 $665,910 - $903,000
-21,000 Reduced 29.58%
50,000 $1.85 Million
Q1 2022

May 13, 2022

SELL
$29.88 - $37.04 $119,520 - $148,160
-4,000 Reduced 5.33%
71,000 $2.63 Million
Q1 2021

May 14, 2021

BUY
$42.51 - $63.78 $3.19 Million - $4.78 Million
75,000 New
75,000 $3.37 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.